Consuming sodium fluoride, a toxic chemical commonly added to US water supplies to allegedly help prevent tooth decay, definitively causes neurodegenerative damage in the brain, spinal cord, and sciatic nerve. These are the findings of a recent study published in the Journal of Medical and Allied Sciences, and ones that, by all scientific standards, put to rest the failed myth that fluoride consumption is in any way safe.
Conducted by K. Pratap Reddy of Osmania University in India, the study confirms that fluoride chemicals “cross the blood-brain barrier and alter the structure and function of neural tissue.” Repeated exposure to fluoride chemicals in test rats was found to lower body weights; reduce the organic somatic index of their brains; and contaminate their hippocampus, neocortex, cerebellum, spinal cord, and sciatic nerve tissues with persistent fluoride chemicals.
The blood-brain barrier is the body’s natural way of protecting the brain and central nervous system from damage by harmful toxins. In other words, it is meant to allow only nutrients and other beneficial metabolic products access to the brain, while filtering out all other materials.
But fluoride chemicals possess uniquely harmful characteristics that allow them to bypass this protective barrier and lodge themselves within brain tissue. The end result is a cascade of neurodegeneration throughout the brain and central nervous system, which in turn can lead to a host of severe and potentially deadly conditions, some of which are irreversible.
Compared to rats not given sodium fluoride, those given the chemicals as part of the study experienced “vacuolation of Schwann cells with enlarged axons and disrupted myelin sheaths” in their sciatic nerves; “irregular nuclei with normal nucleoli, vacuolated cytosol and axons with split myelin,” in their spinal cords; and altered morphology in cerebellar tissue that resulted in “dumbbell shaped and [crenulated] nuclear membrane.”
In simple terms, these changes signify severe neurological damage that can manifest itself in a variety of different ways. Lowered IQ, reduced cognitive function, learning disabilities, and hyperactivity are some of the forms of brain damage caused by fluoride consumption.
Almost two years after the law was passed, New Jersey lawmakers finally announced last week that the state’s medical marijuana program — the most restrictive medicinal cannabis law in the United States — would be fully functional sometime in 2012.
Gov. Chris Christie had issued a surprise announcement in July that the state would go forward with its often-stalled medical marijuana program, reports John Farley at Thirteen.
The Garden State’s medicinal cannabis program has been in transition for months now. In 2010, the State Senate passed the Compassionate Care Act, which required the state to license six medical marijuana dispensaries.
But even though an overwhelming 86 percent of New Jersey voters support medicinal cananbis, Christie put the program on hold, seeking assurance from federal officials that state marijuana workers and doctors would not be prosecuted, reported the Star-Ledger.
That assurance never came, of course. But Gov. Christie, a former federal prosecutor himself, felt that a memo from the U.S. Department of Justice indicated that agency would follow President Barack Obama’s campaign promise in 2008 not to prioritize prosecution of medical marijuana patients and providers who were abiding by state laws.
The Cole Memo [PDF] suggested that the federal government did not consider it “an efficient use of resources” to enforce penalties on terminally ill patients using cannabis for medicinal reasons.
In July, Christie gave New Jersey’s medical marijuana program the green light. But since that announcement, the program has suffered multiple setbacks, none of which were caused by the federal government.
State zoning boards rejected four of the six proposed grow sites and dispensary locations, supposedly due to worries about weak oversight, along with the usual concern that marijuana is still against federal law and the archaic “not in my back yard” (NIMBY) sentiment among some residents when it comes to cannabis.
But on November 29, the Christie Administration said New Jersey’s troubles implementing the system — including dispensary and greenhouse locations — had been ironed out and they were confident that the strict rules governing the program would enable it to avoid federal prosecution.
Though the state will not make its original deadline of December 31, 2011, the medical marijuana program will definitely by up and running some time in 2012, reports Susan K. Livio at the Star Ledger.
New Jersey’s medical marijuana law is the most restrictive of the 16 states states (plus the District of Columbia) that have such programs, according to Politifact. The state limits cannabis authorizations to patients with terminal illnesses or cases where conventional medication has failed, such as glaucoma or epileps
What’s more, doctors in New Jersey can only authorize medicinal cannabis for patients they’ve been seeing for over than a year.
Both the quantity and the quality of cannabis that may be legally possessed is quite limited in New Jersey. State patients may only receive two ounces of marijuana every 30 days.
And in one of those rules that could only have been passed by a Legislature which didn’t know what the hell they were legislating about, New Jersey is the first state to limit the potency of medical marijuana, in this case to 10 percent.
Madam Speaker, I rise to speak about Hemp History Week. To celebrate the American heritage of growing industrial hemp, the Hemp Industries Association, Vote Hemp, several American manufacturers, and allied companies and organizations have declared May 17 to May 23 to be Hemp History Week. Throughout the week, people will recognize America’s legacy of industrial hemp farming and call for reinstating respect for farmers’ basic right to grow industrial hemp.
Industrial hemp was legally grown throughout our country for many years. In fact, George Washington and Thomas Jefferson grew industrial hemp and used it to make cloth. During World War II, the federal government encouraged American farmers to grow hemp to help the war effort.
Despite industrial hemp farming being an important part of American history, the federal government has banned cultivation of this crop. In every other industrialized country, industrial hemp, defined to contain less than 0.3 percent THC — the psychoactive chemical found in marijuana — may be legally grown. Nobody can be psychologically affected by consuming industrial hemp. Unfortunately, because of a federal policy that does not distinguish between growing industrial hemp and growing marijuana, all hemp products and materials must be imported. The result is high prices, outsourced jobs, and lost opportunities for American manufacturing.
Fluoxetine (also known by the tradenames Prozac, Sarafem, Fontex) is an antidepressant of the selective serotonin reuptake inhibitor (SSRI) class. It is manufactured and marketed by Eli Lilly and Company. In combination with olanzapine it is known as Symbyax.
Prozac may represent an archetypal example of how fluoride affects the personality. This drug is approximately 30% fluoride by weight and marketed as an antidepressant, even while a major side effect of its use and/or withdrawal is suicidal depression. Modern psychiatry often treats depressive disorders - the “dark night of the soul” - as an organic disorder of the brain, targeting serotonin reuptake by any chemical means necessary. Fluoride and fluoxetine, in fact, may accomplish their intended “therapeutic effects” by poisoning the pineal gland. Animal studies confirm that when mice have their pineal glands removed they no longer respond to fluoxetine. Source
Perhaps the primary reason why Prozac causes a favorable reaction in those who use it, is that it disassociates that person from the psychospiritual conflicts that they must normally suppress in order to maintain the appearance of sanity and functionality in society, i.e. it is control and not health that is the goal of such “treatment.”
If Prozac and other sources of fluoride in our environment deposits within the pineal gland, accelerating the transformation of functional pineal tissue into calcification, is it possible that it works by dehumanizing and flattening the affect of those who are under its influence?
Washington Gov. Chris Gregoire and Rhode Island Gov. Lincoln Chafee have filed a petition with the U.S. Drug Enforcement Administration asking the agency to reclassify marijuana so doctors can prescribe it and pharmacists can fill the prescription.
The governors said Wednesday they want the federal government to list marijuana as a Schedule 2 drug, allowing it to be used for medical treatment. Marijuana is currently classified a Schedule 1 drug, meaning it’s not accepted for medical treatment and can’t be prescribed, administered or dispensed.
Washington and Rhode Island are two of 16 states, and the District of Columbia, that have laws allowing the medical use of marijuana.
“Each of these jurisdictions is struggling with managing safe access to medical cannabis for patients with serious medical conditions,” the 99-page petition and report reads. “Our work with the federal agencies has not resolved the matter.”
Gregoire said that the conflict between state and federal laws means legitimate patients lack a regulated and safe system to obtain marijuana.
“It is time to show compassion and time to show common sense,” she said in a conference call with reporters Wednesday.